Award
Delivery Order #SPE2DR26FAVQA
AmerisourceBergen Awarded Delivery Order for Nirsevimab Medication Supply
Buyer
Defense Logistics Agency
Award Amount
$1,486.08
Ceiling
$1,486.08
Awarded
February 23, 2026
Period of Performance
Feb 23, 2026 – Feb 24, 2026
Identifier
SPE2DR26FAVQA
NAICS
325411
This award is a delivery order contract issued to AmerisourceBergen Drug Corporation, a prominent pharmaceutical services company specializing in the distribution of medicines and healthcare products. The contract involves the procurement of Nirsevimab 50mg prefilled syringes, a critical pharmaceutical product. This specific delivery order supports the broader indefinite delivery vehicle (IDV) held by AmerisourceBergen for European pharmaceutical procurement, highlighting a strategic role in the agency's efforts to ensure the availability of essential medical treatments. The scope includes the supply and timely delivery of this medication to the specified location in Conshohocken, Pennsylvania. The award follows under the existing IDV contract framework and was likely awarded through established procurement channels associated with that vehicle, ensuring competitive and reliable sourcing. The performance period of this delivery order is short-term, spanning approximately one day in early 2026, indicating a focused and immediate fulfillment requirement. This contract exemplifies the ongoing partnership to maintain pharmaceutical supply chains and addresses critical healthcare needs promptly.
Description
4570913567!NIRSEVIMAB 50MG PFS 5S